Keywords Topics Show all (3) (-) Antiretroviral Therapy (ART) (3) Rapid Start of ART (2) Type ShareSpot Post (3) Publication Date Show all (3) (-) 2018 (3) Displaying 1 - 3 of 3 Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 04/11/2018 Immediate ART Initiation Improves Time to Viral Suppression Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 04/11/2018 Rapid ART Start Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 10/16/2018
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 04/11/2018
Immediate ART Initiation Improves Time to Viral Suppression Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 04/11/2018
Rapid ART Start Susa Coffey National AETC Support Center, UCSF Center for HIV Information ShareSpot Post, published 10/16/2018
